LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), today announced it has named Mike Norris as Vice President of Corporate Development. In this position, Mr. Norris will be responsible for leading the development of CVBT’s global corporate business, infrastructure, sales and market strategies. He reports to Mickael Flaa, vice president and CFO of CardioVascular BioTherapeutics.
